Nandan Mandayam O, Ghaleb Amr M, Bialkowska Agnieszka B, Yang Vincent W
Department of Medicine, Stony Brook University School of Medicine, HSC-T16 Room 020, Stony Brook, NY 11794, United States.
Department of Medicine, Stony Brook University School of Medicine, HSC-T16 Room 020, Stony Brook, NY 11794, United States.
Stem Cell Res. 2015 Jan;14(1):10-9. doi: 10.1016/j.scr.2014.10.008. Epub 2014 Nov 6.
Krüppel-like factor 5 (KLF5) is a pro-proliferative transcription factor that is expressed in dividing epithelial cells of the intestinal crypt. Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) has been identified as a stem cell marker in both small intestinal and colonic epithelial cells. To determine whether KLF5 regulates proliferation of intestinal stem cells, we investigated the effects of Klf5 deletion specifically from the intestinal stem cells in adult mice. Mice with inducible intestinal stem cell-specific deletion of Klf5 (Lgr5-Klf5(fl/fl)) were injected with tamoxifen for 5 consecutive days to induce Lgr5-driven Cre expression. Intestinal and colonic tissues were examined by immunohistochemistry at various time points up to 112days following start of tamoxifen treatment. Klf5 is co-localized in the crypt-based columnar (CBC) cells that express Lgr5. By 11days following the start of tamoxifen treatment, Lgr5-positive crypts from which Klf5 was deleted exhibited a loss of proliferation that was accompanied by an increase in apoptosis. Beginning at 14days following the start of tamoxifen treatment, both Klf5 expression and proliferation were re-established in the transit-amplifying epithelial cells but not in the Lgr5-positive CBC cells. By 112days post-treatment, up to 90% of the Lgr5-positive cells from which Klf5 was deleted were lost from the intestinal crypts. These results indicate a critical role for KLF5 in the survival and maintenance of intestinal stem cells.
Krüppel样因子5(KLF5)是一种促进增殖的转录因子,在小肠隐窝中分裂的上皮细胞中表达。富含亮氨酸重复序列的G蛋白偶联受体5(Lgr5)已被确定为小肠和结肠上皮细胞中的干细胞标志物。为了确定KLF5是否调节肠道干细胞的增殖,我们研究了在成年小鼠肠道干细胞中特异性缺失Klf5的影响。对可诱导肠道干细胞特异性缺失Klf5的小鼠(Lgr5-Klf5(fl/fl))连续5天注射他莫昔芬以诱导Lgr5驱动的Cre表达。在开始他莫昔芬治疗后的长达112天的不同时间点,通过免疫组织化学检查肠道和结肠组织。Klf5与表达Lgr5的隐窝基底柱状(CBC)细胞共定位。在开始他莫昔芬治疗后的11天,缺失Klf5的Lgr5阳性隐窝显示增殖丧失,并伴有细胞凋亡增加。从开始他莫昔芬治疗后的14天开始,Klf5表达和增殖在过渡放大上皮细胞中重新建立,但在Lgr5阳性CBC细胞中未重新建立。治疗后112天,缺失Klf5的Lgr5阳性细胞中高达90%从小肠隐窝中消失。这些结果表明KLF5在肠道干细胞的存活和维持中起关键作用。